• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nature . SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

tetano

Editor, Senior Moderator
Nature


. 2020 Jul 15.
doi: 10.1038/s41586-020-2550-z. Online ahead of print.
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls


Nina Le Bert[SUP] 1 [/SUP], Anthony T Tan[SUP] 1 [/SUP], Kamini Kunasegaran[SUP] 1 [/SUP], Christine Y L Tham[SUP] 1 [/SUP], Morteza Hafezi[SUP] 1 [/SUP], Adeline Chia[SUP] 1 [/SUP], Melissa Hui Yen Chng[SUP] 1 [/SUP], Meiyin Lin[SUP] 1 2 [/SUP], Nicole Tan[SUP] 1 [/SUP], Martin Linster[SUP] 1 [/SUP], Wan Ni Chia[SUP] 1 [/SUP], Mark I-Cheng Chen[SUP] 3 [/SUP], Lin-Fa Wang[SUP] 1 [/SUP], Eng Eong Ooi[SUP] 1 [/SUP], Shirin Kalimuddin[SUP] 4 [/SUP], Paul Anantharajal Tambyah[SUP] 5 6 [/SUP], Jenny Guek-Hong Low[SUP] 1 4 [/SUP], Yee-Joo Tan[SUP] 2 7 [/SUP], Antonio Bertoletti[SUP] 8 9 [/SUP]



Affiliations

Abstract

Memory T cells induced by previous pathogens can shape the susceptibility to, and clinical severity of, subsequent infections[SUP]1[/SUP]. Little is known about the presence of pre-existing memory T cells in humans with the potential to recognize SARS-CoV-2. Here, we first studied T cell responses to structural (nucleocapsid protein, NP) and non-structural (NSP-7 and NSP13 of ORF1) regions of SARS-CoV-2 in COVID-19 convalescents (n=36). In all of them we demonstrated the presence of CD4 and CD8 T cells recognizing multiple regions of the NP protein. We then showed that SARS-recovered patients (n=23) still possess long-lasting memory T cells reactive to SARS-NP 17 years after the 2003 outbreak, which displayed robust cross-reactivity to SARS-CoV-2 NP. Surprisingly, we also frequently detected SARS-CoV-2 specific T cells in individuals with no history of SARS, COVID-19 or contact with SARS/COVID-19 patients (n=37). SARS-CoV-2 T cells in uninfected donors exhibited a different pattern of immunodominance, frequently targeting the ORF-1-coded proteins NSP7 and 13 as well as the NP structural protein. Epitope characterization of NSP7-specific T cells showed recognition of protein fragments with low homology to "common cold" human coronaviruses but conserved amongst animal betacoranaviruses. Thus, infection with betacoronaviruses induces multispecific and long-lasting T cell immunity to the structural protein NP. Understanding how pre-existing NP- and ORF-1-specific T cells present in the general population impact susceptibility and pathogenesis of SARS-CoV-2 infection is of paramount importance for the management of the current COVID-19 pandemic.
 
Back
Top Bottom